loadpatents
Patent applications and USPTO patent grants for KINSELLA; Todd.The latest application filed is for "in vivo engineered cereblon protein".
Patent | Date |
---|---|
In Vivo Engineered Cereblon Protein App 20220298213 - WEINSTEIN; David ;   et al. | 2022-09-22 |
TGF-beta inhibitors Grant 11,352,360 - Kinsella , et al. June 7, 2 | 2022-06-07 |
Tgf- Inhibitors App 20210276982 - Gelman; Marina ;   et al. | 2021-09-09 |
TGF- inhibitors Grant 11,021,468 - Gelman , et al. June 1, 2 | 2021-06-01 |
Tgf- Inhibitors App 20210130361 - Gelman; Marina ;   et al. | 2021-05-06 |
In Vivo Engineered Cereblon Protein App 20210002337 - WEINSTEIN; David ;   et al. | 2021-01-07 |
2,3-Disubstituted pyridine compounds as TGF-.beta. inhibitors and methods of use Grant 10,858,335 - Singh , et al. December 8, 2 | 2020-12-08 |
TGF-.beta. inhibitorC Grant 10,822,337 - Gelman , et al. November 3, 2 | 2020-11-03 |
Antigen Binding Molecules To Tigit App 20200339678 - Bhatt; Ramesh R. ;   et al. | 2020-10-29 |
In vivo engineered cereblon protein Grant 10,781,239 - Weinstein , et al. Sept | 2020-09-22 |
Antigen binding molecules to TIGIT Grant 10,759,855 - Bhatt , et al. Sep | 2020-09-01 |
Fused imidazole derivatives as TGF-beta inhibitors Grant 10,696,693 - Singh , et al. June 30, 2 | 2020-06-30 |
TGF-Beta Inhibitors App 20200031832 - Kinsella; Todd ;   et al. | 2020-01-30 |
2,3-Disubstituted Pyridine Compounds as TGF-Beta Inhibitors and Methods of Use App 20190284155 - Singh; Rajinder ;   et al. | 2019-09-19 |
TGF-.beta. inhibitors Grant 10,287,295 - Kinsella , et al. | 2019-05-14 |
2,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use Grant 10,233,170 - Singh , et al. | 2019-03-19 |
Fused Imidazole Derivatives as TGF-Beta Inhibitors App 20180346487 - Singh; Rajinder ;   et al. | 2018-12-06 |
TGF- Inhibitors App 20180339979 - Gelman; Marina ;   et al. | 2018-11-29 |
Antigen Binding Molecules To Tigit App 20180155422 - Bhatt; Ramesh R. ;   et al. | 2018-06-07 |
GDF-8 inhibitors Grant 9,981,944 - Ding , et al. May 29, 2 | 2018-05-29 |
TGF-Beta Inhibitors App 20180127426 - Kinsella; Todd ;   et al. | 2018-05-10 |
TGF- Inhibitors App 20180086764 - Gelman; Marina ;   et al. | 2018-03-29 |
TGF-beta inhibitors Grant 9,884,868 - Kinsella , et al. February 6, 2 | 2018-02-06 |
GDF-8 inhibitors Grant 9,878,992 - Bhamidipati , et al. January 30, 2 | 2018-01-30 |
GDF-8 Inhibitors App 20170342048 - Bhamidipati; Somasekhar ;   et al. | 2017-11-30 |
2,3-Disubstituted Pyridine Compounds as TGF-Beta Inhibitors and Methods of Use App 20170096409 - Singh; Rajinder ;   et al. | 2017-04-06 |
GDF-8 inhibitors Grant 9,518,040 - Bhamidipati , et al. December 13, 2 | 2016-12-13 |
Methods for using carboxamide, sulfonamide and amine compounds Grant 9,511,058 - Payan , et al. December 6, 2 | 2016-12-06 |
GDF-8 Inhibitors App 20160264553 - Ding; Pingyu ;   et al. | 2016-09-15 |
TGF-Beta Inhibitors App 20160257690 - Kinsella; Todd ;   et al. | 2016-09-08 |
GDF-8 Inhibitors App 20160052909 - Bhamidipati; Somasekhar ;   et al. | 2016-02-25 |
GDF-8 inhibitors Grant 9,145,433 - Bhamidipati , et al. September 29, 2 | 2015-09-29 |
Methods For Using And Biomarkers For Ampk-activating Compounds App 20150087673 - Hitoshi; Yasumichi ;   et al. | 2015-03-26 |
Methods for Using Carboxamide, Sulfonamide and Amine Compounds App 20140323460 - Payan; Donald ;   et al. | 2014-10-30 |
Methods for using carboxamide, sulfonamide and amine compounds Grant 8,796,254 - Payan , et al. August 5, 2 | 2014-08-05 |
GDF-8 Inhibitors App 20140107073 - Bhamidipati; Somasekhar ;   et al. | 2014-04-17 |
Method Of Treating Muscular Degradation App 20130310340 - Payan; Donald G. ;   et al. | 2013-11-21 |
Methods for Using Carboxamide, Sulfonamide and Amine Compounds App 20110245222 - Payan; Donald ;   et al. | 2011-10-06 |
Compositions and methods for screening and identifying anti-HCV agents App 20030219723 - Lu, Henry H. ;   et al. | 2003-11-27 |
Cyclic peptides and analogs useful to treat allergies App 20030166138 - Kinsella, Todd ;   et al. | 2003-09-04 |
Rapid, stable high-titre production of recombing retrovirus Grant 5,830,725 - Nolan , et al. November 3, 1 | 1998-11-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.